These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35811843)

  • 41. Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes.
    Xu Y; Gao J; Gong Y; Chen M; Chen J; Zhao W; Tan S
    Atherosclerosis; 2020 Mar; 297():111-119. PubMed ID: 32109664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation.
    Syed GH; Tang H; Khan M; Hassanein T; Liu J; Siddiqui A
    J Virol; 2014 Mar; 88(5):2519-29. PubMed ID: 24352472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect and mechanism of the Ang-(1-7) on human mesangial cells injury induced by low density lipoprotein.
    Huang W; Tang L; Cai Y; Zheng Y; Zhang L
    Biochem Biophys Res Commun; 2014 Jul; 450(2):1051-7. PubMed ID: 24978313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5-Azacytidine engages an IRE1α-EGFR-ERK1/2 signaling pathway that stabilizes the LDL receptor mRNA.
    Mnasri N; Mamarbachi M; Allen BG; Mayer G
    Biochim Biophys Acta Gene Regul Mech; 2018 Jan; 1861(1):29-40. PubMed ID: 29208426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK pathway.
    Adachi S; Homoto M; Tanaka R; Hioki Y; Murakami H; Suga H; Matsumoto M; Nakayama KI; Hatta T; Iemura S; Natsume T
    Nucleic Acids Res; 2014 Sep; 42(15):10037-49. PubMed ID: 25106868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.
    Rashid S; Tavori H; Brown PE; Linton MF; He J; Giunzioni I; Fazio S
    Circulation; 2014 Jul; 130(5):431-41. PubMed ID: 25070550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism.
    Zeng L; Liao H; Liu Y; Lee TS; Zhu M; Wang X; Stemerman MB; Zhu Y; Shyy JY
    J Biol Chem; 2004 Nov; 279(47):48801-7. PubMed ID: 15358760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. White tea and its active polyphenols lower cholesterol through reduction of very-low-density lipoprotein production and induction of LDLR expression.
    Luo K; Ma C; Xing S; An Y; Feng J; Dang H; Huang W; Qiao L; Cheng J; Xie L
    Biomed Pharmacother; 2020 Jul; 127():110146. PubMed ID: 32334376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Cholesterol-Lowering Effect of Capsella Bursa-Pastoris Is Mediated via SREBP2 and HNF-1α-Regulated PCSK9 Inhibition in Obese Mice and HepG2 Cells.
    Hwang JT; Choi E; Choi HK; Park JH; Chung MY
    Foods; 2021 Feb; 10(2):. PubMed ID: 33673187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
    Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
    Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A lipidomics study reveals hepatic lipid signatures associating with deficiency of the LDL receptor in a rat model.
    Wang HY; Quan C; Hu C; Xie B; Du Y; Chen L; Yang W; Yang L; Chen Q; Shen B; Hu B; Zheng Z; Zhu H; Huang X; Xu G; Chen S
    Biol Open; 2016 Jul; 5(7):979-86. PubMed ID: 27378433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice.
    Wang S; Miller B; Matthan NR; Goktas Z; Wu D; Reed DB; Yin X; Grammas P; Moustaid-Moussa N; Shen CL; Lichtenstein AH
    Nutr Res; 2013 Dec; 33(12):1072-82. PubMed ID: 24267047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of LDL Uptake in Human Cells by Targeting the LDLR Regulatory Long Non-coding RNA BM450697.
    Ray RM; Hansen AH; Slott S; Taskova M; Astakhova K; Morris KV
    Mol Ther Nucleic Acids; 2019 Sep; 17():264-276. PubMed ID: 31279228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake.
    Nelson JK; Cook EC; Loregger A; Hoeksema MA; Scheij S; Kovacevic I; Hordijk PL; Ovaa H; Zelcer N
    J Biol Chem; 2016 Feb; 291(9):4813-25. PubMed ID: 26719329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
    Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
    Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic S1P deficiency lowers plasma cholesterol levels in apoB-containing lipoproteins when LDLR function is compromised.
    Basu D; Huq A; Iqbal J; Hussain MM; Jiang XC; Jin W
    Nutr Metab (Lond); 2015; 12():35. PubMed ID: 26495026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proprotein Convertase Subtilisin/Kexin-Type 9 and Lipid Metabolism.
    Guo S; Xia XD; Gu HM; Zhang DW
    Adv Exp Med Biol; 2020; 1276():137-156. PubMed ID: 32705598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
    Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
    Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.